3-Bromo-2,2-dimethylpropanoyl fluoride, 5g

(S)-1-((Benzyloxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 98%, 100mg

(2E)-1-(2,5-dimethoxyphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

4,5-dihydronaphtho[1,2-b]thiophene-2-carboxylic acid, 95.0%, 1g

8-Chloroquinolin-2-ol, 95.0%, 1g

(6-(Methoxycarbonyl)pyridin-3-yl)boronic acid, 95.0%, 5g

3-Bromo-5-isopropylpyridine, 97%, 250mg

2-Aminomethyl-benzooxazole, 97.0%, 1g

6-Amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile, 98%, 25g

Methyl 4-amino-3-bromo-2-methylbenzoate, 95.0%, 1g

Methyl 2-(2-(indolin-1-ylsulfonyl)-4,5-dimethoxyphenyl)acetate, 95%, 1g

Phase contrast Abbe condenser with slide for E-Plan EPLPH 20/S100 phase contrast objectives, slide with 20 and 100x phases, telescope and green filter

2-(3-Bromophenyl)propanoic acid, 95.0%, 250mg